Ali Farhoudi

716 total citations
16 papers, 595 citations indexed

About

Ali Farhoudi is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ali Farhoudi has authored 16 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 12 papers in Epidemiology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ali Farhoudi's work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (11 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Ali Farhoudi is often cited by papers focused on Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (11 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Ali Farhoudi collaborates with scholars based in Belgium, France and United Kingdom. Ali Farhoudi's co-authors include Geert Leroux‐Roels, Philip Meuleman, Lieven Verhoye, Isabelle Desombere, Freya Van Houtte, Harvey J. Alter, Jens Bukh, Peter Vanlandschoot, Ibrahim M. Sayed and Jacques Izopet and has published in prestigious journals such as Hepatology, Gut and Journal of Hepatology.

In The Last Decade

Ali Farhoudi

16 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Farhoudi Belgium 11 514 400 125 120 64 16 595
Aster Beyene United States 9 319 0.6× 279 0.7× 116 0.9× 80 0.7× 25 0.4× 10 439
Shingo Takikawa United States 6 304 0.6× 262 0.7× 110 0.9× 39 0.3× 22 0.3× 8 366
A. Uy Germany 11 499 1.0× 474 1.2× 75 0.6× 62 0.5× 44 0.7× 15 592
Ermei Yao United States 8 299 0.6× 262 0.7× 35 0.3× 69 0.6× 63 1.0× 11 371
Olivier Vidalin France 8 306 0.6× 249 0.6× 42 0.3× 53 0.4× 73 1.1× 8 413
Jocelyne Rémiré France 12 693 1.3× 614 1.5× 61 0.5× 79 0.7× 26 0.4× 17 750
Françoise Darthuy France 13 727 1.4× 651 1.6× 61 0.5× 84 0.7× 27 0.4× 17 793
Agoritsa Varaklioti Greece 12 361 0.7× 268 0.7× 44 0.4× 55 0.5× 27 0.4× 17 533
HJ Alter United States 6 286 0.6× 260 0.7× 73 0.6× 94 0.8× 111 1.7× 10 490
Emiko Takai Japan 11 311 0.6× 461 1.2× 92 0.7× 92 0.8× 161 2.5× 17 587

Countries citing papers authored by Ali Farhoudi

Since Specialization
Citations

This map shows the geographic impact of Ali Farhoudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Farhoudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Farhoudi more than expected).

Fields of papers citing papers by Ali Farhoudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Farhoudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Farhoudi. The network helps show where Ali Farhoudi may publish in the future.

Co-authorship network of co-authors of Ali Farhoudi

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Farhoudi. A scholar is included among the top collaborators of Ali Farhoudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Farhoudi. Ali Farhoudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Desombere, Isabelle, Freya Van Houtte, Ali Farhoudi, et al.. (2021). A Role for B Cells to Transmit Hepatitis C Virus Infection. Frontiers in Immunology. 12. 775098–775098. 5 indexed citations
2.
Sayed, Ibrahim M., Lander Foquet, Lieven Verhoye, et al.. (2017). Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma. Antiviral Research. 141. 150–154. 41 indexed citations
3.
Desombere, Isabelle, Ahmed Atef Mesalam, Richard A. Urbanowicz, et al.. (2017). A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo. Antiviral Research. 148. 53–64. 20 indexed citations
4.
Mesalam, Ahmed Atef, Isabelle Desombere, Ali Farhoudi, et al.. (2017). Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1. Virology. 514. 30–41. 8 indexed citations
5.
Tödt, Daniel, Koen Vercauteren, C. Patrick McClure, et al.. (2017). Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy. Antiviral Research. 139. 129–137. 4 indexed citations
6.
Sayed, Ibrahim M., Lieven Verhoye, Laurence Cocquerel, et al.. (2016). Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut. 66(5). 920–929. 106 indexed citations
7.
Vercauteren, Koen, Richard J. P. Brown, Ahmed Atef Mesalam, et al.. (2015). Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice. Gut. 65(12). 2029–2034. 22 indexed citations
8.
Prentoe, Jannick, Lieven Verhoye, Rodrigo Velázquez‐Moctezuma, et al.. (2015). HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice. Gut. 65(12). 1988–1997. 38 indexed citations
9.
Vercauteren, Koen, Richard J. P. Brown, Ahmed Atef Mesalam, et al.. (2015). G09 : Targeting a host-cell entry factor barricades antiviral resistant HCV variants from on-therapy breakthrough in human-liver mice. Journal of Hepatology. 62. S214–S214. 1 indexed citations
10.
Desombere, Isabelle, Samira Fafi‐Kremer, Freya Van Houtte, et al.. (2015). Monoclonal anti‐envelope antibody AP33 protects humanized mice against a patient‐derived hepatitis C virus challenge. Hepatology. 63(4). 1120–1134. 32 indexed citations
11.
Meuleman, Philip, Maria Teresa Catanese, Lieven Verhoye, et al.. (2011). A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo. Hepatology. 55(2). 364–372. 112 indexed citations
12.
Meuleman, Philip, Jens Bukh, Lieven Verhoye, et al.. (2011). In Vivo Evaluation of the Cross-Genotype Neutralizing Activity of Polyclonal Antibodies Against Hepatitis C Virus Δσ. Hepatology. 53(3). 755–762. 108 indexed citations
13.
Vanlandschoot, Peter, et al.. (2002). Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. Journal of General Virology. 83(6). 1281–1289. 43 indexed citations
14.
Vanlandschoot, Peter, Freya Van Houtte, Ali Farhoudi, et al.. (2002). LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles. Journal of General Virology. 83(9). 2279–2289. 38 indexed citations
15.
Leroux‐Roels, Geert, Tinghua Cao, Philip Meuleman, et al.. (2001). PREVENTION OF HEPATITIS B INFECTIONS : VACCINATION AND ITS LIMITATIONS. Acta Clinica Belgica. 56(4). 209–219. 16 indexed citations
16.
Farhoudi, Ali. (1986). Cell-mediated immunodeficiency after BCG vaccination.. PubMed. 58 ( Pt A). 347–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aster Beyene Breakdown of academic impact, for papers by Shingo Takikawa Breakdown of academic impact, for papers by A. Uy Breakdown of academic impact, for papers by Ermei Yao Breakdown of academic impact, for papers by Olivier Vidalin Breakdown of academic impact, for papers by Jocelyne Rémiré Breakdown of academic impact, for papers by Françoise Darthuy Breakdown of academic impact, for papers by Agoritsa Varaklioti Breakdown of academic impact, for papers by HJ Alter Breakdown of academic impact, for papers by Emiko Takai
Rankless by CCL
2026